therapeutic 1,724 words KG: ent-dise-bfd8f32d 2026-03-24
section:therapeuticskind:therapeutictopic:cbstopic:psptopic:extracellular-matrixtopic:integrin-signalingtopic:mmp-inhibitorstopic:laminintopic:hyaluronantopic:perineuronal-nettopic:bbbtopic:drug-delivery
Contents

Section 138: Advanced Extracellular Matrix and Integrin Therapy in CBS/PSP

💊 Therapeutic Info
NameSection 138: Advanced Extracellular Matrix and Integrin Therapy in CBS/PSP
SummaryAdvanced extracellular matrix and integrin-targeting therapies for CBS/PSP: ECM remodeling, integrin signaling modulators, MMP inhibitors, laminin therapy, hyaluronan therapy, perineuronal net digestion, BBB ECM, ECM-based drug delivery, patient-specific considerations

Knowledge Graph

Related Hypotheses (30)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Purinergic Signaling Polarization Control
Score: 0.55
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
Microglia-Derived Extracellular Vesicle Engineering for Targ
Score: 0.37

Related Analyses (27)

4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Do tau strains or regional cellular environments primarily d
neurodegeneration · failed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived

Related Experiments (13)

4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40

See Also (15)

Extracellular Vesicle and Tunneling Nanotube-Mediated S
mechanism · Pages share 5 hypotheses
ALS Therapeutic Landscape — Programs by Phase and Modal
disease · Pages share 4 hypotheses
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 4 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 4 hypotheses